Skip to main content
Premium Trial:

Request an Annual Quote

Quanterix SR-X Ultra-Sensitive Biomarker Detection System

Quanterix has announced the commercial availability of its SR-X Ultra-Sensitive Biomarker Detection system, powered by the firm's Simoa technology. The research-use-only system lets users design assays to detect both proteins and nucleic acids directly from blood, as well as several other complex sample types. The SR-X enables measurement of nucleic acid levels, including miRNA, without using PCR. The platform is designed to detect up to six biomarkers per sample, with low volume requirements, the company said.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.